Nyrada Commences Phase I Clinical Trial Recruitment

Highlights:
•Participant recruitment has now commenced in Nyrada’s Phase Ia first-in-human clinical trial.
•Phase I trial designed to assess safety, tolerability, and pharmacokinetics of lead drug candidate NYR-BI03.
•First participant dosing expected before end of March 2025.
•Scientia Clinical Research is the clinical trial site and Southern Star Research is providing Contract Research Organisation services.